NoIR 15% Medium Amber SpectraShield Large, 401-38
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are specialized low vision sunglasses with an amber tint that blocks 100% of UV light while allowing only 15% of visible light through — a combination that reduces glare significantly more than standard sunglasses. They're designed for people with conditions like macular degeneration, glaucoma, diabetic retinopathy, or cataracts, where sensitivity to bright light and glare is a daily challenge. The SpectraShield frame includes a top ridge and built-in side shields to block light from above and the sides, and the glasses fit over most prescription frames. The 15% transmission is quite dark, so they're best suited for bright outdoor environments or very strong artificial lighting — not for indoor or low-light use.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Put on the glasses — they fit over most prescription eyewear and are ready to use immediately.
- Use outdoors or in bright artificial lighting environments where glare is a problem.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.